This is a working overview of drug affinity complex, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-12. Anything still debated is marked as such rather than presented as settled.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
== Reception == Spin wrote, "The spirits of Little Richard, Chuck Berry and dozens of anonymous honkers and shouters haunt the grooves. Fishbone charges through the six cuts at breakneck speed. Tunes jump jaggedly from one change to another, flashing a frantic ska-beat, squawking horns, growling guitars, nearly a capella harmonies, yelps, squeaks, guffaws and moans."
When electron transfer is reduced (by a high membrane potential or respiratory inhibitors such as antimycin A), Complex III may leak electrons to molecular oxygen, resulting in superoxide formation. This complex is inhibited by dimercaprol (British Anti-Lewisite, BAL), naphthoquinone and antimycin.
== DPP-4 mechanism == Fig.1: During a meal, the incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent gastric inhibitory polypeptide (GIP) are released by the small intestine into the blood stream. These hormones regulate insulin secretion in a glucose-dependent manner. (GLP-1 has many roles in the human body. It stimulates insulin biosynthesis, inhibits glucagon secretion, slows gastric emptying, reduces appetite and stimulates regeneration of islet β-cells.) GLP-1 and GIP have extremely short plasma half-lives due to very rapid inactivation, catalyzed by the enzyme DPP-4. Inhibition of DPP-4 slows their inactivation, thereby potentiating their action, leading to lower plasma glucose levels, hence its utility in the treatment of type 2 diabetes. (Figure 1).
Sources: en.wikipedia.org
Realizing that he cannot win with brute force, Neo allows Smith to assimilate him, which enables the machines to eradicate the Smith virus directly through his body. Unfortunately, the process also kills Neo. Neo's body is taken away by the machines in the Machine City, while below in Zion, the machines stop their attack and depart in deference to the peace that Neo bartered. The Matrix is rebooted and a beautiful sunrise appears over the horizon, created by Sati in Neo's honor.
These are a major forum for scientific and medical knowledge exchange and is allied with a large exhibition of In Vitro Diagnostic industry equipment. The Quality and Regulations Committee is particularly focussed on contributing to revisions of International standards such ISO 15189 and ISO 22870 which govern standards in medical laboratories; they also contribute to European Regulations and Directives such as the IVD (In Vitro Diagnostics) Regulations. These regulations and standards ensure quality results are delivered for patient care a key issue in diagnosis and monitoring of health and disease and are under regular international review. The Communications Committee provides information on EFLM activities to members and promotes awareness of EFLM The Profession Committee is responsible for the Register of Specialists in Laboratory Medicine and that applicants meet the standards set for eligibility. The need for comparable attainments of qualification, education and experience is a patient safety issue as patients can freely move across borders. All offices are by election. Member societies have national representatives who vote on behalf of their society. The only automatic office is President who will have been elected as Vice President. Working group members are chosen from member society nominations. The journal published by De Gruyter, Clinical Chemistry and Laboratory Medicine is the EFLM official journal. To date two strategic conferences have been held to advance the profession in Europe:
=== Biochemical studies === In the late 1980s, copper peptide GHK-Cu started attracting attention as a promising wound healing agent. At picomolar to nanomolar concentrations, GHK-Cu stimulated the synthesis of collagen in skin fibroblasts, increased accumulation of total proteins, glycosaminoglycans (in a biphasic curve) and DNA in the dermal wounds in rats. They also found out that the GHK sequence is present in collagen and suggested that the GHK peptide is released after tissue injury. They proposed a class of emergency response molecules which are released from the extracellular matrix at the site of an injury. GHK-Cu also increased synthesis of decorin – a small proteoglycan involved in the regulation of collagen synthesis, wound healing regulation and anti-tumor defense. GHK-Cu has been shown to produce anti-inflammatory effects and stimulate release of growth factors such as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2). It was also established that GHK-Cu stimulates both the synthesis of metalloproteinases, the enzymes which break down dermal proteins, and their inhibitors (anti-proteases). The fact that GHK-Cu not only stimulates the production of dermal components, but also regulates their breakdown suggests that it should be used with caution.
The physiology of cardiac muscle shares many similarities with that of skeletal muscle. The primary function of both muscle types is to contract, and in both cases, a contraction begins with a characteristic flow of ions across the cell membrane known as an action potential. The cardiac action potential subsequently triggers muscle contraction by increasing the concentration of calcium within the cytosol.
Sources: en.wikipedia.org
The inner walls of the capsule are then rinsed with a dilute NaOH solution to collect iodine as soluble iodide (I−) and hypoiodite (IO−), according to the standard disproportionation reaction of halogens in alkaline solution. Any caesium atom present immediately oxidizes and passes into the water as Cs+. In order to eliminate any long-lived 135Cs and 137Cs which may be present in small amounts, the solution is passed through a cation-exchange column, which exchanges Cs+ for another non-radioactive cation (e.g., Na+). The radioiodine (as anion I− or IO−) remains in solution as a mixture of iodide and hypoiodite.
Airstrikes on industrial and fuel hubs have released a chronic toxic cocktail of benzene, heavy metals, and persistent 'forever chemicals' (PFAS), triggering 'black rain' in major cities and causing long-term health degradation for civilians. The high oil prices driven by wars in the Middle East, including Iran, created a surge in profits of oil companies, pushing them to increase production as opposed to targets set by the Paris climate agreement. The planned expansion is projected to exceed the International Energy Agency's regular scenario – a 5.9% increase in oil and gas production in the 2020s, leading to a 2.9 °C (5.2 °F) global temperature increase.
Platt, Harris & Tishkoff (2026) reconstruct likely patterns of interbreeding between Neanderthals and anatomically modern humans on the basis of the study of their X chromosomes, interpreted as indicating that their interbreeding predominantly involved Neanderthal men mating with anatomically modern women. Evidence from the study of Middle and Upper Paleolithic assemblages, indicating that overall anatomically modern human occupations can be distinguished from Neanderthal ones on the basis of tighter and more cohesive clusters of archaeological remains, is presented by Merino-Pelaz & Cobo-Sánchez (2026). Evidence of utility of the study of nonmetric traits at the enamel-dentine junction for distinguishing teeth of Neanderthals and modern humans is presented by Becam, Chevalier & Colard (2026). Kanis et al. (2026) identify amino acid changes in the growth hormone receptor of Neanderthals, including a change driving faster cell growth, and report evidence of more muscle mass in modern humans who inherited the gene encoding the Neanderthal growth hormone receptor through admixture. Zhang et al. (2026) present a new method for identification of evidence of archaic ancestry in modern human genomes, and report evidence of an introgression from an unknown archaic lineage into the ancestors of modern humans before their migration out of Africa. Evidence of effectiveness of the imputation in detection of Neanderthal and Denisovan ancestry in low-coverage ancient genomes is presented by Capodiferro et al. (2026) . Rao et al.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.